Skip to main content
Log in

Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis

  • Review Article
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Laryngeal cancer is the second most common cancer of the respiratory tract with a relative 5-year survival over all tumour sites in the USA (61.6%; SEER 2009), which is much better than other head and neck cancers. The aim of this paper is to review and summarise data on the survival of laryngeal cancer patients. Literature search was conducted to identify articles in PubMed up to June 2009. Thirty studies with different study aims including sufficient information on survival of laryngeal cancer patients were identified. The 5-year overall survival ranged from 0 to 100%, depending on the T- and N-category, therapeutic approach and tumour location. The involvement of other factors such as genetics, nutrition and lifestyle habits remains uncertain. Our meta-analysis on a subgroup of published studies yielded an overall 5-year relative survival rate of 64.2% (95% confidence interval 63.7–64.7%). Different study aims and patient selection criteria prohibit general conclusions. However, this review may provide an actual picture of the complexity of factors influencing the survival of laryngeal cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Ferlay J, Bray F, Pisani P, Parkin D (2001) GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. IARC cancer base no. 5, IARC, Lyon, version 1.0

  2. Ramroth H, Dietz A, Becher H (2004) Interaction effects and population-attributable risks for smoking and alcohol on laryngeal cancer and its subsites. A case–control study from Germany. Methods Inf Med 43:499–504. doi:10.1267/METH04050499

    CAS  PubMed  Google Scholar 

  3. Shangina O, Brennan P, Szeszenia-Dabrowska N, Mates D, Fabiánová E, Fletcher T et al (2006) Occupational exposure and laryngeal and hypopharyngeal cancer risk in central and eastern Europe. Am J Epidemiol 164:367–375. doi:10.1093/aje/kwj208

    Article  PubMed  Google Scholar 

  4. Talamini R, Bosetti C, Vecchia CL, Maso LD, Levi F, Bidoli E et al (2002) Combined effect of tobacco and alcohol on laryngeal cancer risk: a case–control study. Cancer Causes Control 13:957–964

    Article  CAS  PubMed  Google Scholar 

  5. Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D et al (2007) Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe. Am J Epidemiol 165:814–820. doi:10.1093/aje/kwk066

    Article  PubMed  Google Scholar 

  6. IARC (2003) Monographs on the evaluation of carcinogenic risks to humans tobacco smoke and involuntary smoking. IARC, Lyon, p 83

    Google Scholar 

  7. Ramroth H, Dietz A, Becher H (2008) Environmental tobacco smoke and laryngeal cancer: results from a population-based case–control study. Eur Arch Otorhinolaryngol 265:1367–1371. doi:10.1007/s00405-008-0651-7

    Article  PubMed  Google Scholar 

  8. Lee YCA, Boffetta P, Sturgis EM, Wei Q, Zhang ZF, Muscat J et al (2008) Involuntary smoking and head and neck cancer risk: pooled analysis in the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev 17:1974–1981. doi:10.1158/1055-9965.EPI-08-0047

    Article  PubMed  Google Scholar 

  9. Becher H, Ramroth H, Ahrens W, Risch A, Schmezer P, Dietz A (2005) Occupation, exposure to polycyclic aromatic hydrocarbons and laryngeal cancer risk. Int J Cancer 116:451–457. doi:10.1002/ijc.21049

    Article  CAS  PubMed  Google Scholar 

  10. Ramroth H, Dietz A, Ahrens W, Becher H (2008) Occupational wood dust exposure and the risk of laryngeal cancer: a population based case–control study in Germany. Am J Ind Med 51:648–655. doi:10.1002/ajim.20605

    Article  PubMed  Google Scholar 

  11. Boffetta P, Richiardi L, Berrino F, Estève J, Pisani P, Crosignani P et al (2003) Occupation and larynx and hypopharynx cancer: an international case–control study in France, Italy, Spain, and Switzerland. Cancer Causes Control 14:203–212

    Article  PubMed  Google Scholar 

  12. Dietz A, Ramroth H, Urban T, Ahrens W, Becher H (2004) Exposure to cement dust, related occupational groups and laryngeal cancer risk: results of a population based case–control study. Int J Cancer 108:907–911. doi:10.1002/ijc.11658

    Article  CAS  PubMed  Google Scholar 

  13. http://seer.cancer.gov/csr/1975_2006/results_merged/topic_survival.pdf

  14. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R et al (2009) EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 45:931–991. doi:10.1016/j.ejca.2008.11.018

    Article  PubMed  Google Scholar 

  15. Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ et al (2006) American society of clinical oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24:3693–3704. doi:10.1200/JCO.2006.07.4559

    Article  PubMed  Google Scholar 

  16. Holsinger FC, Weber RS (2007) Swing of the surgical pendulum: a return to surgery for treatment of head and neck cancer in the 21st century? Int J Radiat Oncol Biol Phys 69:S129–S131. doi:10.1016/j.ijrobp.2007.05.044

    PubMed  Google Scholar 

  17. Boscolo-Rizzo P, Maronato F, Marchiori C, Gava A, Mosto MCD (2008) Long-term quality of life after total laryngectomy and postoperative radiotherapy versus concurrent chemoradiotherapy for laryngeal preservation. Laryngoscope 118:300–306. doi:10.1097/MLG.0b013e31815a9ed3

    Article  PubMed  Google Scholar 

  18. Chen AY, Matson LK, Roberts D, Goepfert H (2001) The significance of comorbidity in advanced laryngeal cancer. Head Neck 23:566–572

    Article  CAS  PubMed  Google Scholar 

  19. Piccirillo JF, Lacy PD, Basu A, Spitznagel EL (2002) Development of a new head and neck cancer-specific comorbidity index. Arch Otolaryngol Head Neck Surg 128:1172–1179

    PubMed  Google Scholar 

  20. Sabin SL, Rosenfeld RM, Sundaram K, Har-el G, Lucente FE (1999) The impact of comorbidity and age on survival with laryngeal cancer. Ear Nose Throat J 78:578, 581–578, 584

    Google Scholar 

  21. Castro MAF, Dedivitis RA, Ribeiro KCB (2007) Comorbidity measurement in patients with laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 69:146–152. doi:10.1159/000099223

    PubMed  Google Scholar 

  22. Dietz A, Boehm A, Mozet C, Wichmann G, Giannis A (2008) Current aspects of targeted therapy in head and neck tumors. Eur Arch Otorhinolaryngol 265(Suppl 1):S3–S12. doi:10.1007/s00405-008-0697-6

    Article  PubMed  Google Scholar 

  23. Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26:3582–3589. doi:10.1200/JCO.2007.14.8841

    Article  CAS  PubMed  Google Scholar 

  24. Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J et al (2009) Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101:498–506. doi:10.1093/jnci/djp007

    Article  CAS  PubMed  Google Scholar 

  25. Lefebvre JL, Ang KK, Panel LPC (2009) Larynx preservation clinical trial design: key issues and recommendations—a consensus panel summary. Int J Radiat Oncol Biol Phys 73:1293–1303

    Article  PubMed  Google Scholar 

  26. Dietz A, Boehm A, Horn IS, Kruber P, Bechmann I, Golusinski W et al (2010) Assay-based response evaluation in head and neck oncology: requirements for better decision making. Eur Arch Otorhinolaryngol 267:483–494. doi:10.1007/s00405-009-1191-5

    Article  PubMed  Google Scholar 

  27. Wittekind C, Sobin L (2002) TNM classification of malignant tumours. Wiley-Liss, New York

    Google Scholar 

  28. Molina MA, Cheung MC, Perez EA, Byrne MM, Franceschi D, Moffat FL et al (2008) African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients. Cancer 113:2797–2806. doi:10.1002/cncr.23889

    Article  PubMed  Google Scholar 

  29. Sutton A, Abrams K, Jones D, Sheldon T, Song F (2000) Methods for meta-analysis in medical research. Wiley, Chichester

    Google Scholar 

  30. Cantor AB (2001) Projecting the standard error of the Kaplan–Meier estimator. Stat Med 20:2091–2097. doi:10.1002/sim.856

    Article  CAS  PubMed  Google Scholar 

  31. Dikshit RP, Boffetta P, Bouchardy C, Merletti F, Crosignani P, Cuchi T et al (2005) Lifestyle habits as prognostic factors in survival of laryngeal and hypopharyngeal cancer: a multicentric European study. Int J Cancer 117:992–995. doi:10.1002/ijc.21244

    Article  CAS  PubMed  Google Scholar 

  32. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H et al (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261–269. doi:10.1093/jnci/djn011

    Article  CAS  PubMed  Google Scholar 

  33. Adamopoulos G, Yotakis I, Apostolopoulos K, Manolopoulos L, Kandiloros D, Ferekidis E (1997) Supraglottic laryngectomy-series report and analysis of results. J Laryngol Otol 111:730–734

    Article  CAS  PubMed  Google Scholar 

  34. Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ et al (2006) Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 116:1–13. doi:10.1097/01.mlg.0000236095.97947.26

    Article  PubMed  Google Scholar 

  35. Rachet B, Quinn MJ, Cooper N, Coleman MP (2008) Survival from cancer of the larynx in England and Wales up to 2001. Br J Cancer 99(Suppl 1):S35–S37. doi:10.1038/sj.bjc.6604581

    Article  PubMed  Google Scholar 

  36. Raitiola H, Pukander J, Laippala P (1999) Glottic and supraglottic laryngeal carcinoma: differences in epidemiology, clinical characteristics and prognosis. Acta Otolaryngol 119:847–851

    Article  CAS  PubMed  Google Scholar 

  37. LaRosa F, Petrinelli AM, Stracci F, Ammetto C, Casucci P, Mastrandrea V (2000) Long term survival of upper aerodigestive tract cancer in male patients in the Umbria region (Italy). Eur J Epidemiol 16:489–494

    Article  CAS  Google Scholar 

  38. Tamura Y, Tanaka S, Asato R, Hirano S, Yamashita M, Tamaki H, et al. (2007) Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years. Acta Otolaryngol Suppl, pp 62–65. doi:10.1080/00016480601067990

  39. DiMartino E, Sellhaus B, Hausmann R, Minkenberg R, Lohmann M, Esthofen MW (2002) Survival in second primary malignancies of patients with head and neck cancer. J Laryngol Otol 116:831–838. doi:10.1258/00222150260293664

    Article  Google Scholar 

  40. Olthoff A, Ewen A, Wolff H, Hermann R, Vorwerk H, Hille A et al (2009) Organ function and quality of life after transoral laser microsurgery and adjuvant radiotherapy for locally advanced laryngeal cancer. Strahlenther Onkol 185:303–309. doi:10.1007/s00066-009-1967-y

    Article  PubMed  Google Scholar 

  41. Fung K, Lyden TH, Lee J, Urba SG, Worden F, Eisbruch A et al (2005) Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Int J Radiat Oncol Biol Phys 63:1395–1399. doi:10.1016/j.ijrobp.2005.05.004

    Article  PubMed  Google Scholar 

  42. Preuss SF, Cramer K, Klussmann JP, Eckel HE, Guntinas-Lichius O (2009) Transoral laser surgery for laryngeal cancer: outcome, complications and prognostic factors in 275 patients. Eur J Surg Oncol 35:235–240. doi:10.1016/j.ejso.2008.01.012

    CAS  PubMed  Google Scholar 

  43. Cabanillas R, Rodrigo JP, Llorente JL, Suárez C (2008) Oncologic outcomes of transoral laser surgery of supraglottic carcinoma compared with a transcervical approach. Head Neck 30:750–755. doi:10.1002/hed.20778

    Article  PubMed  Google Scholar 

  44. Motta S, Moscillo L, Imperiali M, Motta G (2003) CO2 laser treatment of bilateral vocal cord paralysis in adduction. ORL J Otorhinolaryngol Relat Spec 65:359–365. doi:10.1159/000076055

    CAS  PubMed  Google Scholar 

  45. Hartl DM, de Monès E, Hans S, Janot F, Brasnu D (2007) Treatment of early-stage glottic cancer by transoral laser resection. Ann Otol Rhinol Laryngol 116:832–836

    PubMed  Google Scholar 

  46. Ansarin M, Santoro L, Cattaneo A, Massaro MA, Calabrese L, Giugliano G et al (2009) Laser surgery for early glottic cancer: impact of margin status on local control and organ preservation. Arch Otolaryngol Head Neck Surg 135:385–390. doi:10.1001/archoto.2009.10

    Article  PubMed  Google Scholar 

  47. Hinni ML, Salassa JR, Grant DG, Pearson BW, Hayden RE, Martin A et al (2007) Transoral laser microsurgery for advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 133:1198–1204. doi:10.1001/archotol.133.12.1198

    Article  PubMed  Google Scholar 

  48. Prades JM, Simon PG, Timoshenko AP, Dumollard JM, Schmitt T, Martin C (2005) Extended and standard supraglottic laryngectomies: a review of 110 patients. Eur Arch Otorhinolaryngol 262:947–952. doi:10.1007/s00405-004-0882-1

    Article  PubMed  Google Scholar 

  49. Pellini R, Pichi B, Ruscito P, Ceroni AR, Caliceti U, Rizzotto G et al (2008) Supracricoid partial laryngectomies after radiation failure: a multi-institutional series. Head Neck 30:372–379. doi:10.1002/hed.20709

    Article  PubMed  Google Scholar 

  50. Piazza C, Peretti G, Cattaneo A, Garrubba F, Zinis LORD, Nicolai P (2007) Salvage surgery after radiotherapy for laryngeal cancer: from endoscopic resections to open-neck partial and total laryngectomies. Arch Otolaryngol Head Neck Surg 133:1037–1043. doi:10.1001/archotol.133.10.1037

    Article  PubMed  Google Scholar 

  51. Santos CR, Kowalski LP, Magrin J, Fogaroli RC, Santos JC, Sabóia MV et al (1998) Prognostic factors in supraglottic carcinoma patients treated by surgery or radiotherapy. Ann Otol Rhinol Laryngol 107:697–702

    CAS  PubMed  Google Scholar 

  52. Sevilla MA, Rodrigo JP, Llorente JL, Cabanillas R, López F, Suárez C (2008) Supraglottic laryngectomy: analysis of 267 cases. Eur Arch Otorhinolaryngol 265:11–16. doi:10.1007/s00405-007-0415-9

    Article  PubMed  Google Scholar 

  53. Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW (2001) T1–T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 19:4029–4036

    CAS  PubMed  Google Scholar 

  54. Reddy SP, Hong RL, Nagda S, Emami B (2007) Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience. Int J Radiat Oncol Biol Phys 69:1389–1394. doi:10.1016/j.ijrobp.2007.05.077

    Article  PubMed  Google Scholar 

  55. Kao J, Lavaf A, Teng MS, Huang D, Genden EM (2008) Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage. Int J Radiat Oncol Biol Phys 71:362–370. doi:10.1016/j.ijrobp.2007.09.058

    Article  PubMed  Google Scholar 

  56. Rusthoven KE, Raben D, Chen C (2008) Improved survival in patients with stage III–IV head and neck cancer treated with radiotherapy as primary local treatment modality. Int J Radiat Oncol Biol Phys 72:343–350. doi:10.1016/j.ijrobp.2007.12.046

    Article  PubMed  Google Scholar 

  57. Nguyen-Tan PF, Le QT, Quivey JM, Singer M, Terris DJ, Goffinet DR et al (2001) Treatment results and prognostic factors of advanced T3–4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience. Int J Radiat Oncol Biol Phys 50:1172–1180

    Article  CAS  PubMed  Google Scholar 

  58. Spector JG, Sessions DG, Lenox J, Simpson J (2006) Management of T3N1 glottic carcinoma: therapeutic outcomes. Laryngoscope 116:106–110. doi:10.1097/01.mlg.0000184767.62682.3d

    Article  PubMed  Google Scholar 

  59. MacKenzie RG, Franssen E, Balogh JM, Gilbert RW, Birt D, Davidson J (2000) Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients eligible for surgery. Int J Radiat Oncol Biol Phys 47:65–71

    Article  CAS  PubMed  Google Scholar 

  60. Herchenhorn D, Dias FL, Ferreira CG, Araújo CM, Lima RA, Small IA et al (2008) Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiation. ORL J Otorhinolaryngol Relat Spec 70:381–388. doi:10.1159/000163034

    CAS  PubMed  Google Scholar 

  61. Johnson J (2006) Outcomes in laryngeal cancer: a product of the learning curve? Laryngoscope 116:1529. doi:10.1097/01.mlg.0000236092.52123.a9

    Article  PubMed  Google Scholar 

  62. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945–1952

    Article  CAS  PubMed  Google Scholar 

  63. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937–1944

    Article  PubMed  Google Scholar 

  64. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European organization for research and treatment of cancer phase III trial. EORTC head and neck cancer cooperative group. J Natl Cancer Inst 88:890–899

    Article  CAS  PubMed  Google Scholar 

  65. The Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685–1690. doi:10.1056/NEJM199106133242402

    Article  Google Scholar 

  66. Pignon JP, le Maître A, Maillard E, Bourhis J, MACHNCC Group (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17, 346 patients. Radiother Oncol 92:4–14. doi:10.1016/j.radonc.2009.04.014

    Article  PubMed  Google Scholar 

  67. Higgins KM, Wang JR (2008) State of head and neck surgical oncology research—a review and critical appraisal of landmark studies. Head Neck 30:1636–1642. doi:10.1002/hed.20863

    Article  PubMed  Google Scholar 

  68. Dietz A, Rudat V, Dreyhaupt J, Pritsch M, Hoppe F, Hagen R et al (2009) Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial). Eur Arch Otorhinolaryngol 266:1291–1300. doi:10.1007/s00405-008-0846-y

    Article  PubMed  Google Scholar 

  69. Forastiere AA, Trotti A, Pfister DG, Grandis JR (2006) Head and neck cancer: recent advances and new standards of care. J Clin Oncol 24:2603–2605. doi:10.1200/JCO.2006.07.1464

    Article  PubMed  Google Scholar 

  70. Hanna E, Sherman A, Cash D, Adams D, Vural E, Fan CY et al (2004) Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Arch Otolaryngol Head Neck Surg 130:875–879. doi:10.1001/archotol.130.7.875

    Article  PubMed  Google Scholar 

  71. Oates J, Clark JR, Read J, Reeves N, Gao K, O’Brien CJ (2008) Integration of prospective quality of life and nutritional assessment as routine components of multidisciplinary care of patients with head and neck cancer. ANZ J Surg 78:34–41. doi:10.1111/j.1445-2197.2007.04353.x

    Article  PubMed  Google Scholar 

  72. Hoffmann M, Görögh T, Gottschlich S, Lohrey C, Rittgen W, Ambrosch P et al (2005) Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients. Cancer Lett 218:199–206. doi:10.1016/j.canlet.2004.09.027

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The work of Elisabeth Rudolph was supported in part by a DFG grant from the GRK 793 Graduate College: “Epidemiology of communicable and chronic, non-communicable diseases and their interrelationships” at the University Hospital at Heidelberg.

Conflict of interest

The authors declare no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Heribert Ramroth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rudolph, E., Dyckhoff, G., Becher, H. et al. Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis. Eur Arch Otorhinolaryngol 268, 165–179 (2011). https://doi.org/10.1007/s00405-010-1395-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-010-1395-8

Keywords

Navigation